ID17491A - Mutein-mutein interleukin-4 afinitas tinggi - Google Patents

Mutein-mutein interleukin-4 afinitas tinggi

Info

Publication number
ID17491A
ID17491A IDP972537A ID972537A ID17491A ID 17491 A ID17491 A ID 17491A ID P972537 A IDP972537 A ID P972537A ID 972537 A ID972537 A ID 972537A ID 17491 A ID17491 A ID 17491A
Authority
ID
Indonesia
Prior art keywords
muteins
interleukin
afinity
high afinity
interleukin muteins
Prior art date
Application number
IDP972537A
Other languages
English (en)
Inventor
Jefrey Greve
Armen B Shanafelt
Steven Roczniak
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of ID17491A publication Critical patent/ID17491A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6869—Interleukin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5406—IL-4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Wood Science & Technology (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IDP972537A 1996-07-19 1997-07-21 Mutein-mutein interleukin-4 afinitas tinggi ID17491A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68780396A 1996-07-19 1996-07-19

Publications (1)

Publication Number Publication Date
ID17491A true ID17491A (id) 1998-01-08

Family

ID=24761912

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP972537A ID17491A (id) 1996-07-19 1997-07-21 Mutein-mutein interleukin-4 afinitas tinggi

Country Status (24)

Country Link
EP (1) EP0939817B1 (id)
JP (1) JP2000515016A (id)
KR (1) KR100468553B1 (id)
CN (1) CN1201006C (id)
AR (2) AR007917A1 (id)
AT (1) ATE310821T1 (id)
AU (1) AU718794B2 (id)
BR (1) BR9710733B1 (id)
CA (1) CA2259940C (id)
DE (1) DE69734723T2 (id)
DK (1) DK0939817T3 (id)
ES (1) ES2252786T3 (id)
HK (1) HK1022717A1 (id)
HU (1) HU224973B1 (id)
ID (1) ID17491A (id)
IL (2) IL127934A0 (id)
MY (1) MY124565A (id)
NZ (2) NZ505238A (id)
PL (1) PL188738B1 (id)
RU (1) RU2202364C2 (id)
TR (1) TR199900100T2 (id)
TW (1) TW496871B (id)
WO (1) WO1998003654A2 (id)
ZA (1) ZA976368B (id)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0911401A1 (en) * 1997-10-21 1999-04-28 Bayer Ag Muteins of interleukin 4 showing low-affinity and short-term interaction with the common gamma chain
EP1022337B1 (en) * 1999-01-20 2006-07-26 Bayer HealthCare AG Plasmids, their construction and their use in the manufacture of interleukin-4 and interleukin-4 muteins
EP1022339B1 (en) 1999-01-20 2006-02-01 Bayer HealthCare AG Plasmids, their construction and their use in the manufacture of interleukin-4 and interleukin-4 muteins
CN1306030C (zh) * 2001-09-28 2007-03-21 中山大学 一种人白细胞介素－10基因序列及含该基因序列的大肠杆菌
BRPI0406789A (pt) * 2003-01-17 2006-01-17 Childrens Hosp Medical Center Composição farmacêutica e métodos de intensificação de expressão do fator-2 do trefoil (tff2), de avaliação fisiológica pulmonar, de tratamento e de intensificação da restauração de tecido inflamado induzido por alérgeno
US7404957B2 (en) * 2003-08-29 2008-07-29 Aerovance, Inc. Modified IL-4 mutein receptor antagonists
US7785580B2 (en) 2003-08-29 2010-08-31 Aerovance, Inc. Modified IL-4 mutein receptor antagonists
WO2007082068A2 (en) * 2006-01-11 2007-07-19 Aerovance, Inc. Methods and compositions for treating asthma in human and non human primates
WO2017001568A1 (en) 2015-07-01 2017-01-05 Universitat De Lleida Treatment and prevention of amyotrophic lateral sclerosis
US20220235344A1 (en) * 2018-12-19 2022-07-28 Biopharma Translationsinstitut Dessau Forschungs Gmbh Trypsin variants with improved enzymatic properties
CN113527485A (zh) * 2020-04-17 2021-10-22 上海麦济生物技术有限公司 抗人白细胞介素-4受体α抗体及其制备方法和应用
CN112442504B (zh) * 2020-12-10 2023-01-24 电子科技大学 一种重组草鱼白介素-12活性蛋白的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU620537B2 (en) * 1986-12-19 1992-02-20 Immunex Corporation Human interleukin-4 muteins
DE4137333A1 (de) * 1991-11-13 1993-05-19 W Prof Dr Sebald Therapeutische mittel, die antagonisten oder partielle agonisten des humanen interleukin 4 sind oder diese enthalten, hil-4-mutantenproteine sowie vefahren zu deren herstellung
WO1993021308A1 (en) * 1992-04-17 1993-10-28 The University Hospital Mutant cytokines having increased receptor affinity
CA2256459A1 (en) * 1996-06-14 1997-12-18 Bayer Corporation T-cell selective interleukin-4 agonists

Also Published As

Publication number Publication date
TW496871B (en) 2002-08-01
ES2252786T3 (es) 2006-05-16
CA2259940A1 (en) 1998-01-29
HUP0000248A2 (hu) 2000-06-28
DE69734723T2 (de) 2006-06-22
WO1998003654A3 (en) 1998-05-14
JP2000515016A (ja) 2000-11-14
ZA976368B (en) 1998-02-19
AU718794B2 (en) 2000-04-20
DE69734723D1 (de) 2005-12-29
NZ505238A (en) 2001-06-29
PL188738B1 (pl) 2005-04-29
PL331253A1 (en) 1999-07-05
HUP0000248A3 (en) 2003-09-29
AR060630A2 (es) 2008-07-02
KR100468553B1 (ko) 2005-01-29
HU224973B1 (en) 2006-04-28
AU3654597A (en) 1998-02-10
WO1998003654A2 (en) 1998-01-29
DK0939817T3 (da) 2006-01-23
CN1201006C (zh) 2005-05-11
BR9710733B1 (pt) 2012-02-22
CA2259940C (en) 2008-09-23
IL182509A0 (en) 2007-09-20
IL182509A (en) 2011-03-31
BR9710733A (pt) 1999-08-17
AR007917A1 (es) 1999-11-24
RU2202364C2 (ru) 2003-04-20
IL127934A0 (en) 1999-11-30
EP0939817B1 (en) 2005-11-23
TR199900100T2 (xx) 1999-04-21
CN1230223A (zh) 1999-09-29
NZ333748A (en) 2000-08-25
EP0939817A2 (en) 1999-09-08
ATE310821T1 (de) 2005-12-15
MY124565A (en) 2006-06-30
KR20000067914A (ko) 2000-11-25
HK1022717A1 (en) 2000-08-18

Similar Documents

Publication Publication Date Title
DK0809996T3 (da) Interferonkonjugater
DE59403215D1 (de) Luftabscheider
DE69330841D1 (de) Hochleistungsperipherieschnittstelle
BR9704843A (pt) Hidroxifeniltriazinas
DE69526144D1 (de) Leistungsverstärker
ID17491A (id) Mutein-mutein interleukin-4 afinitas tinggi
DE69523988D1 (de) Aufladevorrichtung
DE69429660D1 (de) Brückenverstärker mit hohem Wirkungsgrad
DE69619086D1 (de) Stromintegrator
DE69522153D1 (de) Staubsammelapparat
ID18992A (id) Pelawan interleukin-4 selektif sel-t
DE69522404D1 (de) Aufladevorrichtung
FI941720A0 (fi) Ylijännitesuojaus
DK0481353T3 (da) Højeffektstrømforsyning
KR960013566U (ko) 에어바이스의 구조
KR960005488U (ko) 고효율 압축기
KR970053641U (ko) 집진장치
KR950009365U (ko) 개량 에어 커플러(air coupler)
KR950032226U (ko) 휴대용 집진기구
KR960025539U (ko) 단말기 충전 고정 장치
KR960025540U (ko) 단말기 충전 고정 장치
ID16384A (id) Larutan interferon
UA475S (uk) Зарядний пристрій
KR950025340U (ko) 강력송풍기
KR970006225U (ko) 양측전원 단자를 구비한 환풍기